IP Library Assignment 062981/0931
Patent Assignment
Reel/Frame 062981/0931

Assignment of Assignor's Interest

Recorded: 2023-03-14 Pages: 3
Assignor
DEFREES, SHAWN
Executed: 2007-10-15
Assignee
NEOSE TECHNOLOGIES, INC
102 ROCK ROAD, HORSHAM, PENNSYLVANIA, 19044
Covered Properties (2)
Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
Patent: 9,200,049 →
Application: 13/332,708 →
Publication: US 2012/0172300
A Method of Treating of Fibroblast Growth Factor 21 (Fgf-21) Deficiency
Application: 14/954,696 →
Publication: US 2016/0158319
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 13, 2019
From: RATIOPHARM GMBH
To: 89BIO LTD.
Reel/Frame 048318/0006 →
Assignment of Assignor's Interest Aug 21, 2019
From: RATIOPHARM GMBH; TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.
To: 89BIO LTD.
Reel/Frame 050112/0408 →
Corrective Assignment to Correct the Application Number 62/623342 Previously Recorded on Reel 050112 Frame 0408. Assignor(S) Hereby Confirms the License Assignment. Oct 24, 2019
From: RATIOPHARM GMBH; TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.
To: 89BIO LTD.
Reel/Frame 050817/0001 →
Assignment of Assignor's Interest Jul 8, 2020
From: NOVO NORDISK A/S
To: RATIOPHARM GMBH
Reel/Frame 053147/0057 →
Assignment of Assignor's Interest Mar 14, 2023
From: NEOSE TECHNOLOGIES, INC
To: NOVO NORDISK A/S
Reel/Frame 062981/0963 →
Assignment of Assignor's Interest Oct 6, 2025
From: 89BIO LTD.
To: 89BIO, INC.
Reel/Frame 072478/0305 →